Immix Biopharma
IMMX
IMMX
22 hedge funds and large institutions have $4.9M invested in Immix Biopharma in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$94.7K | |
| 2 | +$92.8K | |
| 3 | +$21.6K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$487 |
Top Sellers
| 1 | -$38.6K | |
| 2 | -$28.1K | |
| 3 | -$28K | |
| 4 |
TAM
Tocqueville Asset Management
New York
|
-$15.1K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$15K |
